Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors
批准号:
9145866
负责人:
RICHARD R. DRAKE
金额:
$25.71万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-08 至 2021-03-31
关键词:
African AmericanAgeArchivesBehaviorBiologicalBiological AssayBiological MarkersBiological ProcessCancer ControlCellsChronic stressClinical ManagementComplexDataDecision MakingDevelopmentDiagnostic Neoplasm StagingDiseaseDisease ProgressionEarly DiagnosisEpidemiologyEquilibriumGleason Grade for Prostate CancerGlucocorticoidsGoalsGuidelinesIL8 geneImageImmuneImmune SeraImmune systemInflammatoryInterleukin-6LinkMalignant neoplasm of prostateMapsMass Spectrum AnalysisMedicalMinorityMolecularOutcomePathway interactionsPerformancePhysiologicalPlayPolysaccharidesPopulationProstate-Specific AntigenProstatic NeoplasmsRecurrenceResearchResearch PersonnelResearch Project GrantsResourcesRiskRoleSamplingSerumSocial ConditionsSouth CarolinaSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStressSurfaceTestingTissuesTumor VolumeTumor stageUniversitiesallostatic loadbasebiological adaptation to stressbiomarker panelcancer biomarkerscancer health disparitycancer initiationclinical decision-makingcohortcontextual factorscytokineearly detection biomarkersimmune functionindexinginnovationmale healthmenprecision medicinepsychologicracial disparityresponsescreeningsocialsocioeconomicsstressortumortumor microenvironmenttumor progressiontwo-dimensional
中文摘要
研究项目2-项目摘要
MUSC TCC项目的目标是开发更精确的前列腺癌起始生物标志物,
进展,并确定如何治疗和管理前列腺癌的少数民族男子的背景下,
他们的生物风险为不良结果和社会,心理和生理(即,非稳态负荷(AL)
压力源这将使用几种新的创新实验方法直接在存档组织上进行
MUSC独有,使用代表约三分之一非洲人的丰富资源样本队列(n=570)
美国(AA)受试者。基于AA男性中前列腺癌的流行病学(已在
的建议),已作出相当大的努力,以促进早期发现,通过筛查,
前列腺特异性抗原(PSA)检测然而,最近,筛查指南已经从性能
从50岁开始的年度筛查到知情决策,因为新数据已经出现,
PSA检测的功效由于早期检测在前列腺癌控制中的作用不那么突出,
更重要的是要确定在启动和进展中激活的生物学途径,
并开发更有效的生物标志物进行早期检测。先前的几项研究表明,
肿瘤微环境和免疫系统之间存在复杂的相互作用,
AA男性患上更严重的前列腺癌然而,生物过程
与免疫功能相关的免疫系统在社会环境因素中运作并受其影响。因此,识别
生物学机制,而不了解它们与社会决定因素的联系方式
是必要的,但不足以长期努力减少前列腺癌结局的种族差异
通过疾病的早期发现和临床管理。一个新出现的假设对这一应用至关重要
关于癌症健康差异的一点是,社会条件和对社会压力源的心理反应
影响对癌症的发生和发展至关重要的生物学过程。在这个项目中,
MUSC的研究人员将通过一项跨学科研究来检验这一假设,
通过评估肿瘤的发生和发展,
免疫系统、肿瘤糖组、社会决定因素和AL之间的微环境相互作用。
这些研究人员将确定前列腺中不同肿瘤和基质N-聚糖的组合是否
AA男性的癌症促进了更促肿瘤的炎症/免疫微环境。他们还将
研究这些生物过程和社会决定因素之间的关系,包括隔离,
感知压力和慢性社会经济压力源。他们假设压力的组合-
诱导社会决定因素,不同的N-聚糖,免疫/炎症平衡受损,
AA人群中的侵袭性前列腺癌。
英文摘要
RESEARCH PROJECT 2- PROJECT SUMMARY
The goal of this MUSC TCC project is to develop more precise biomarkers of prostate cancer initiation and
progression, and determine how to treat and manage prostate cancer among minority men within the context
of their biological risk for poor outcomes and social, psychological, and physiological (i.e., allostatic load/AL)
stressors. This will be done using several new innovative experimental approaches directly on archived tissues
unique to MUSC, using a rich resource cohort of samples (n=570) representing approximately one third African
American (AA) subjects. Based on the epidemiology of prostate cancer among AA men (already described in
the proposal), considerable efforts have been made to promote early detection through screening with
prostate specific antigen (PSA) testing. Recently, however, screening guidelines have shifted from performance
of annual screening starting at age 50 to informed decision-making as new data have emerged about the
efficacy of PSA testing. As early detection plays a less prominent role in prostate cancer control, it becomes
even more important to identify biological pathways that are activated in the initiation and progression of
disease and develop more effective biomarkers for early detection. Several prior studies have shown that
there is a complex interplay between the tumor microenvironment and the immune system that contributes to
the development of more aggressive prostate cancer among AA men. However, biological processes
related to immune functioning operate within and are influenced by social contextual factors. Thus, identifying
biological mechanisms without understanding the ways in which they are associated with social determinants
is necessary, but not sufficient to long-term efforts to reduce racial disparities in prostate cancer outcomes
through early detection and clinical management of disease. An emerging hypothesis central to this application
about cancer health disparities is that social conditions and psychological responses to social stressors
influence biological processes that are important to the initiation and progression of cancer. In this project,
MUSC investigators will examine this hypothesis through a transdisciplinary study that defines the molecular
mechanisms involved in the initiation and progression of prostate cancer by evaluating the tumor
microenvironment interactions between the immune system, the tumor glycome, social determinants and AL.
These investigators will determine whether the combination of distinct tumor and stroma N-glycans in prostate
cancers of AA men promotes a more pro-tumor inflammatory/immune microenvironment. They will also
examine the relationship between these biological processes and social determinants that include isolation,
perceived stress, and chronic socioeconomic stressors. They hypothesize that a combination of stress-
inducing social determinants, distinct N-glycans, impaired immune/inflammatory balance contributes to more
aggressive prostate cancers in the AA population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids
-
批准号:10358217
-
项目类别:
-
资助金额:$33.7万
-
财政年份:2022
-
负责人:RICHARD R. DRAKE
-
依托单位:
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids
-
批准号:10592315
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2022
-
负责人:RICHARD R. DRAKE
-
依托单位:
Proteomics Core
-
批准号:10395946
-
项目类别:
-
资助金额:$17.81万
-
财政年份:2020
-
负责人:RICHARD R. DRAKE
-
依托单位:
Proteomics Core
-
批准号:10608991
-
项目类别:
-
资助金额:$17.81万
-
财政年份:2020
-
负责人:RICHARD R. DRAKE
-
依托单位:
Glycopathology of HCC: identification of the source cells of serum fucosylation
-
批准号:10576851
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2019
-
负责人:RICHARD R. DRAKE
-
依托单位:
Glycopathology of HCC: identification of the source cells of serum fucosylation
-
批准号:9893835
-
项目类别:
-
资助金额:$61.56万
-
财政年份:2019
-
负责人:RICHARD R. DRAKE
-
依托单位:
Glycopathology of HCC: identification of the source cells of serum fucosylation
-
批准号:10361210
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2019
-
负责人:RICHARD R. DRAKE
-
依托单位:
Detection and Histopathology Localization of O-Glycans and Glycosaminoglycans in Tissues
-
批准号:9320983
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2016
-
负责人:RICHARD R. DRAKE
-
依托单位:
Detection and Histopathology Localization of O-Glycans and Glycosaminoglycans in Tissues
-
批准号:9166181
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2016
-
负责人:RICHARD R. DRAKE
-
依托单位:
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors
-
批准号:10562431
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2016
-
负责人:RICHARD R. DRAKE
-
依托单位:
Direct Tumor Glycan Profiling on Tissue Microarrays
-
批准号:9068047
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2015
-
负责人:RICHARD R. DRAKE
-
依托单位:
Glycan Biomarkers of Prostate Cancer in Prostatic Fluids
-
批准号:8211028
-
项目类别:
-
资助金额:$25.49万
-
财政年份:2009
-
负责人:RICHARD R. DRAKE
-
依托单位:
Proximal Prostate Fluids for Protein and miRNA Biomarkers
-
批准号:7586469
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2009
-
负责人:RICHARD R. DRAKE
-
依托单位:
Proximal Prostate Fluids for Protein and miRNA Biomarkers
-
批准号:7795108
-
项目类别:
-
资助金额:$15.79万
-
财政年份:2009
-
负责人:RICHARD R. DRAKE
-
依托单位:
Glycan Biomarkers of Prostate Cancer in Prostatic Fluids
-
批准号:7657071
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2009
-
负责人:RICHARD R. DRAKE
-
依托单位:
Glycan Biomarkers of Prostate Cancer in Prostatic Fluids
-
批准号:8013919
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2009
-
负责人:RICHARD R. DRAKE
-
依托单位:
Proteomic Profiling for Influenza Vaccination/Infection
-
批准号:7060077
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2005
-
负责人:RICHARD R. DRAKE
-
依托单位:
Proteomic Profiling for Influenza Vaccination/Infection
-
批准号:6867063
-
项目类别:
-
资助金额:$28.16万
-
财政年份:2005
-
负责人:RICHARD R. DRAKE
-
依托单位:
ENGINEERED THYMIDINE KINASES FOR CANCER GENE THERAPY
-
批准号:6329097
-
项目类别:
-
资助金额:$10.5万
-
财政年份:1999
-
负责人:RICHARD R. DRAKE
-
依托单位:
ENGINEERED THYMIDINE KINASES FOR CANCER GENE THERAPY
-
批准号:6467347
-
项目类别:
-
资助金额:$9.67万
-
财政年份:1999
-
负责人:RICHARD R. DRAKE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: